EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Cellular Membrane Nanovesicle-Based Vaccine Against Porcine Epidemic Diarrhea Virus

Xianjun Wang, Weibing Zhang, Hong Hu, Wenjing Gao, Xu Ma, Yarong Wu, Yongfeng Qiao iD, Yang Wang, Ding Zhang, Chunbo Dong, Haidong Wang, Zhida Liu iD

Cells · 2026

DOI: 10.3390/cells15020208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Xianjun Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China. Hauptthemen laut MEDLINE: Porcine epidemic diarrhea virus, Viral Vaccines, Cell Membrane, Coronavirus Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Provincial Science and Technology Innovation Young talent team Program, Program Shanxi Provincial Key Research and Development Program, Shanxi Provincial Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine epidemic diarrhea virus (PEDV) has emerged as a major pathogen responsible for porcine diarrheal diseases, causing outbreaks of severe diarrhea and high mortality in neonatal piglets, thereby inflicting severe economic losses on the global swine industry. Current commercial PED vaccines, comprising conventional inactivated and live attenuated formulations, have exhibited progressively diminished efficacy in the face of emerging PEDV variants. The development of high-efficiency vaccine platforms is therefore critical for PED control. This study engineered a cellular membrane nanovesicle (CMN)-based vaccine, which differs from existing inactivated or subunit vaccines by presenting the PEDV spike (S) protein on the cell membranes to mimic the bilayer phospholipid structure of the viral envelope. The full-length S protein (FS, aa 19-1309) or a truncated S protein fragment (TS, aa 19-726) was expressed in Expi293F cells, followed by extraction of cell membranes to assemble antigen-displaying CMN vaccines. Compared with commercial live attenuated vaccine, administration of the CMN vaccine elicited high-titer neutralizing antibodies and elevated IFN-γ-producing CD8+ T cells in murine studies. Safety assessments revealed no adverse effects on body weight, hepatic/renal function indices, or histopathological parameters in vaccinated mice. Furthermore, immunization of piglets elicited notable humoral and CD8+ T cell immune responses. Collectively, the strategy of CMN-based vaccine described herein delivers a potential PEDV vaccine platform, thereby offering a novel avenue for next-generation veterinary vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porcine epidemic diarrhea virusViral VaccinesCell MembraneCoronavirus InfectionsSwine DiseasesAnimalsSwineMiceAntibodies, NeutralizingFemaleMice, Inbred BALB CAntibodies, ViralProtein Subunit VaccinesNanovaccinesCD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

S proteincellular membrane nanovesicleimmune evaluationporcine epidemic diarrhea virusvaccine

Substanzen

Viral VaccinesAntibodies, NeutralizingAntibodies, ViralProtein Subunit VaccinesNanovaccines

Autor:innen und Institutionen

  • College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China.
  • Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China.
  • School of Elite Biomedical Engineers, China Pharmaceutical University, Nanjing 210009, China.
  • School of Biopharmacy, China Pharmaceutical University, Nanjing 210009, China.

ORCID-Profile: Yongfeng Qiao, Zhida Liu

Förderung

  • Shanxi Provincial Science and Technology Innovation Young talent team Program
  • Program Shanxi Provincial Key Research and Development Program
  • Shanxi Provincial Key Research and Development Program

Zitieren

APA

Wang, X., Zhang, W., Hu, H., Gao, W., Ma, X., Wu, Y., Qiao, Y., Wang, Y., Zhang, D., Dong, C., Wang, H., & Liu, Z. (2026). Development of a Cellular Membrane Nanovesicle-Based Vaccine Against Porcine Epidemic Diarrhea Virus. Cells. https://doi.org/10.3390/cells15020208

Vancouver

Wang X, Zhang W, Hu H, Gao W, Ma X, Wu Y, et al. Development of a Cellular Membrane Nanovesicle-Based Vaccine Against Porcine Epidemic Diarrhea Virus. Cells. 2026. doi:10.3390/cells15020208

BibTeX
@article{Wang2026,
  author = {Wang, Xianjun and Zhang, Weibing and Hu, Hong and Gao, Wenjing and Ma, Xu and Wu, Yarong and Qiao, Yongfeng and Wang, Yang and Zhang, Ding and Dong, Chunbo and Wang, Haidong and Liu, Zhida},
  title = {Development of a Cellular Membrane Nanovesicle-Based Vaccine Against Porcine Epidemic Diarrhea Virus},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15020208}
}
Kostenlos starten →